Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
Latest Jobs
Exclusive vacancies may not be shown here, please contact Alana on +44 1494 818 020 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Alana McKenna
Principal Account Manager
+44 1494 818 020

I have worked with Zenopa both in selecting and obtaining a new role. I have found them to be affable, friendly and well informed.
Tony, 2011

GlaxoSmithKline to create jobs with new UK investments

22 March 2012 00:00 in Pharmaceutical Company Restructures

GlaxoSmithKline has announced plans to expand its UK biopharmaceutical manufacturing capabilities, creating up to 1,000 new jobs in the process.

The healthcare company has selected Ulverston in Cumbria as the site for its first new British production facility in almost 40 years, with around 350 million pounds earmarked for its creation.

Meanwhile, more than 100 million pounds has also been allocated for enhancements to GlaxoSmithKline's existing Scottish sites in Montrose and Irvine, which will help to bolster the firm's pharmaceutical pipeline.

The organisation is making these commitments to the UK industry following a confirmation in the Budget that a patent box scheme will be introduced to lower taxation rates on UK-owned intellectual property.

GlaxoSmithKline chief executive officer Sir Andrew Witty said: "The medicines of the future will not only be discovered, but can also continue to be made here in Britain."

Earlier this month, the company also announced the launch of a new multidisciplinary apprenticeship scheme for the UK, which will commence in August 2012.ADNFCR-8000103-ID-801323815-ADNFCR

Other news stories from 22/03/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency

© Copyright 2015 Zenopa Ltd